171 related articles for article (PubMed ID: 38759351)
1. Effect of intravenous immunoglobulin and plasmapheresis on nerve conduction parameters compared to the natural course of Guillain-Barré syndrome.
Kalita J; Mahajan R; Kumar M
J Clin Neurosci; 2024 Jul; 125():76-82. PubMed ID: 38759351
[TBL] [Abstract][Full Text] [Related]
2. Outcome of Guillain-Barré syndrome following intravenous immunoglobulin compared to natural course.
Kalita J; Misra UK; Chaudhary SK; Das M; Mishra A; Ranjan A; Kumar M
Eur J Neurol; 2022 Oct; 29(10):3071-3080. PubMed ID: 35837807
[TBL] [Abstract][Full Text] [Related]
3. Study on Electrophysiological Findings of Guillain Barre Syndrome Patients Attending the Department of Neurology in BSMMU.
Das S; Khan RK; Alam SM; Chowdhury NH; Das P
Mymensingh Med J; 2018 Jul; 27(3):631-640. PubMed ID: 30141456
[TBL] [Abstract][Full Text] [Related]
4. Guillain-Barré syndrome: subtypes and predictors of outcome from India.
Kalita J; Misra UK; Goyal G; Das M
J Peripher Nerv Syst; 2014 Mar; 19(1):36-43. PubMed ID: 24456386
[TBL] [Abstract][Full Text] [Related]
5. Role of IV Immunoglobulin in Indian Children With Guillain-Barré Syndrome.
Kalita J; Kumar M; Misra UK
Pediatr Crit Care Med; 2019 Jul; 20(7):652-659. PubMed ID: 30985608
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Significance of Serial Nerve Conduction in GB Syndrome.
Kalita J; Kumar M; Misra UK
Neurol India; 2022; 70(5):1995-2002. PubMed ID: 36352600
[TBL] [Abstract][Full Text] [Related]
7. Clinical profile of Guillain Barre syndrome.
Dhadke SV; Dhadke VN; Bangar SS; Korade MB
J Assoc Physicians India; 2013 Mar; 61(3):168-72. PubMed ID: 24475678
[TBL] [Abstract][Full Text] [Related]
8. The Efficacy of Intravenous Immunoglobulin in Guillain-Barré Syndrome: The Experience of a Tertiary Medical Center.
Shalem D; Shemer A; Shovman O; Shoenfeld Y; Kivity S
Isr Med Assoc J; 2018 Dec; 20(12):754-760. PubMed ID: 30550005
[TBL] [Abstract][Full Text] [Related]
9. Guillain-Barré syndrome: clinical profile and management.
Sudulagunta SR; Sodalagunta MB; Sepehrar M; Khorram H; Bangalore Raja SK; Kothandapani S; Noroozpour Z; Aheta Sham M; Prasad N; Sunny SP; Mohammed MD; Gangadharappa R; Nidsale Sudarshan R
Ger Med Sci; 2015; 13():Doc16. PubMed ID: 26421004
[TBL] [Abstract][Full Text] [Related]
10. Prospective comparison of acute motor axonal neuropathy and acute inflammatory demyelinating polyradiculoneuropathy in 140 children with Guillain-Barré syndrome in India.
Kalita J; Kumar M; Misra UK
Muscle Nerve; 2018 May; 57(5):761-765. PubMed ID: 29053890
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiological subtypes and prognosis of Guillain-Barré syndrome in northeastern China.
Ye Y; Wang K; Deng F; Xing Y
Muscle Nerve; 2013 Jan; 47(1):68-71. PubMed ID: 23042578
[TBL] [Abstract][Full Text] [Related]
12. The Guillain-Barré syndrome.
Fujimura H
Handb Clin Neurol; 2013; 115():383-402. PubMed ID: 23931791
[TBL] [Abstract][Full Text] [Related]
13. Second IVIg course in Guillain-Barré syndrome patients with poor prognosis (SID-GBS trial): Protocol for a double-blind randomized, placebo-controlled clinical trial.
Walgaard C; Jacobs BC; Lingsma HF; Steyerberg EW; Cornblath DR; van Doorn PA;
J Peripher Nerv Syst; 2018 Dec; 23(4):210-215. PubMed ID: 30151941
[TBL] [Abstract][Full Text] [Related]
14. [Guillain-Barré syndrome in childhood].
Kollár K; Liptai Z; Rosdy B; Móser J
Ideggyogy Sz; 2009 Nov; 62(11-12):399-404. PubMed ID: 20025130
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and outcome of Guillain-Barre syndrome in Saudi Arabia: a multicenter, retrospective study.
Alanazy MH; Bakry SS; Alqahtani A; AlAkeel NS; Alazwary N; Osman AM; Mustafa RA; Al-Harbi TM; Abdulmana SO; Amper AC; Aldughaythir Y; Ali AS; Makkawi S; Maglan A; Alamoudi L; Alsulaiman F; Alabdali M; AlShareef AA; Abuzinadah AR; Bamaga AK
BMC Neurol; 2021 Jul; 21(1):275. PubMed ID: 34253174
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and real-world outcomes of Guillain-Barré syndrome in the Philippines.
I Espiritu A; Separa KJNJ; Milla FJC; Adiao KJB; Leochico CFD; Jamora RDG
Neurol Res; 2021 Dec; 43(12):995-1004. PubMed ID: 34229572
[TBL] [Abstract][Full Text] [Related]
17. Acute axonal neuropathy subtype of Guillain Barré syndrome in a French pediatric series: Adequate follow-up may require repetitive electrophysiological studies.
Chareyre J; Hully M; Simonnet H; Musset L; Barnerias C; Kossorotoff M; Quijano-Roy S; Desguerre I; Gitiaux C
Eur J Paediatr Neurol; 2017 Nov; 21(6):891-897. PubMed ID: 28754297
[TBL] [Abstract][Full Text] [Related]
18. Use of immunoglobulin in severe childhood Guillain-Barré syndrome.
Ortiz-Corredor F; Peña-Preciado M
Acta Neurol Scand; 2007 Apr; 115(4):289-93. PubMed ID: 17376129
[TBL] [Abstract][Full Text] [Related]
19. An electrophysiological classification associated with Guillain-Barré syndrome outcomes.
Hosokawa T; Nakajima H; Unoda K; Yamane K; Doi Y; Ishida S; Kimura F; Hanafusa T
J Neurol; 2014 Oct; 261(10):1986-93. PubMed ID: 25082629
[TBL] [Abstract][Full Text] [Related]
20. [Intravenous immunoglobulin in children with Guillain-Barré syndrome].
Bruck I; Antoniuk SA; Cat R; Spessatto A; Halick SM; Bruyn LR; Rodrigues M; Scola RH; Werneck LC
Arq Neuropsiquiatr; 2000 Dec; 58(4):1081-91. PubMed ID: 11105076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
